{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:15:11Z","timestamp":1792880111319,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Invasive infections from\n                      <jats:italic toggle=\"yes\">Haemophilus influenzae<\/jats:italic>\n                      serotype a (Hia) have been reported with increasing frequency, especially among indigenous populations. However, there are limited population-based studies of clinical severity. We studied invasive Hia infections in Alaska to determine clinical characteristics, mortality and sequelae.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We defined an invasive Hia infection as the first detection of Hia from a usually sterile site in a child &lt;10 years of age from Alaska. We identified cases using the Alaska Invasive Bacterial Diseases Surveillance System and reviewed medical charts up to 2 years after reported illness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We identified invasive Hia infections in 36 children, 28 (78%) &lt;1 year old, 34 (94%) living in an Alaskan village and 25 (69%) without documented underlying illness. Overlapping clinical presentations included meningitis in 15 children (42%); bacteremia and pneumonia in 10 children (28%); and bone, joint or soft tissue infections in 10 children (22%). In 4 other children, no source of invasive infection was identified. Intensive care was provided for 11 children (31%); 12 children (33%) required surgical intervention. One year after infection, 4 children (11%) had died from Hia, and 5 children (14%) had ongoing neurologic sequelae.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Invasive Hia infections in Alaska occurred predominantly in Alaska Native infants in rural communities. Although one-third of children had preexisting conditions, most cases occurred without known comorbidity. Clinical syndromes were frequently severe. One year after infection, 1 in 4 children had either died or had neurologic sequelae. An effective vaccine would prevent significant morbidity and mortality in affected populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000001764","type":"journal-article","created":{"date-parts":[[2017,11,19]],"date-time":"2017-11-19T19:53:25Z","timestamp":1511121205000},"page":"298-303","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Invasive Haemophilus influenzae Serotype a Infection in Children"],"prefix":"10.1097","volume":"37","author":[{"given":"Ian D.","family":"Plumb","sequence":"first","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Danielle","family":"Lecy","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Singleton","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Engel","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hirschfeld","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Keck","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Klejka","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Rudolph","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Hennessy","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Bruce","sequence":"additional","affiliation":[{"name":"Yukon-Kuskokwim Health Corporation, Bethel, AK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.meegid.2009.03.001","article-title":"Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century.","volume":"9","author":"Ulanova","year":"2009","journal-title":"Infect Genet Evol"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1473-3099(13)70170-1","article-title":"Haemophilus influenzae serotype a as a cause of serious invasive infections.","volume":"14","author":"Ulanova","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00006454-198708000-00036","article-title":"Epidemiology of Haemophilus influenzae type b infections in the United States.","volume":"6","author":"Broome","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3201\/eid1401.070822","article-title":"Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005.","volume":"14","author":"Bruce","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/infdis\/153.1.17","article-title":"Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial.","volume":"153","author":"Ward","year":"1986","journal-title":"J Infect Dis"},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1542\/peds.2006-0287","article-title":"The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.","volume":"118","author":"Singleton","year":"2006","journal-title":"Pediatrics"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/cid\/cir735","article-title":"Current epidemiology and trends in invasive Haemophilus influenzae disease\u2013United States, 1989-2008.","volume":"53","author":"MacNeil","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"RR-01","key":"R8-20260107","first-page":"1","article-title":"Prevention and control of haemophilus influenzae type b disease: recommendations of the advisory committee on immunization practices (ACIP).","volume":"63","author":"Briere","year":"2014","journal-title":"MMWR Recomm Rep"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3201\/eid1906.121805","article-title":"Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.","volume":"19","author":"Bruce","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/941461","article-title":"Global epidemiology of invasive Haemophilus influenzae type a disease: do we need a new vaccine?","volume":"2013","author":"Ulanova","year":"2013","journal-title":"J Vaccines"},{"issue":"suppl 2","key":"R11-20260107","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/596494","article-title":"Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region.","volume":"48","author":"Mudhune","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R12-20260107","doi-asserted-by":"crossref","DOI":"10.3402\/ijch.v72i0.20992","article-title":"No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children.","volume":"72","author":"Menzies","year":"2013","journal-title":"Int J Circumpolar Health"},{"key":"R13-20260107","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3201\/eid1603.090290","article-title":"Invasive Haemophilus influenzae Disease, Europe, 1996-2006.","volume":"16","author":"Ladhani","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"R14-20260107","doi-asserted-by":"crossref","first-page":"8937","DOI":"10.1016\/j.vaccine.2011.09.053","article-title":"Changes in serotype distribution of Haemophilus influenzae meningitis isolates identified through laboratory-based surveillance following routine childhood vaccination against H. influenzae type b in Brazil.","volume":"29","author":"Zanella","year":"2011","journal-title":"Vaccine"},{"key":"R15-20260107","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/INF.0b013e31812f4f5b","article-title":"Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.","volume":"26","author":"McConnell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20260107","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1086\/651165","article-title":"Invasive Haemophilus influenzae disease in Utah children: an 11-year population-based study in the era of conjugate vaccine.","volume":"50","author":"Bender","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R17-20260107","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.inf.0000160954.90881.29","article-title":"Outbreak of invasive Haemophilus influenzae serotype a disease.","volume":"24","author":"Hammitt","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20260107","doi-asserted-by":"crossref","first-page":"p.21142","DOI":"10.3402\/ijch.v72i0.21142","article-title":"The epidemiology of invasive disease due to Haemophilus influenzae serotype a in the Canadian North from 2000 to 2010.","volume":"72","author":"Rotondo","year":"2013","journal-title":"Int J Circumpolar Health"},{"key":"R19-20260107","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/428047","article-title":"Epidemiology of invasive Haemophilus influenzae type A disease among Navajo and White Mountain Apache children, 1988-2003.","volume":"40","author":"Millar","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R20-20260107","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1128\/JCM.00102-07","article-title":"Real-time PCR for determining capsular serotypes of Haemophilus influenzae.","volume":"45","author":"Maaroufi","year":"2007","journal-title":"J Clin Microbiol"},{"key":"R24-20260107","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2015.07.080","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska.","volume":"33","author":"Bruce","year":"2015","journal-title":"Vaccine"},{"key":"R25-20260107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2013\/828730","article-title":"Emergence of non-serotype b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in northwestern Ontario.","volume":"24","author":"Sadeghi-Aval","year":"2013","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R26-20260107","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1086\/345863","article-title":"Prevention of Haemophilus influenzae type b (Hib) meningitis and emergence of serotype replacement with type a strains after introduction of Hib immunization in Brazil.","volume":"187","author":"Ribeiro","year":"2003","journal-title":"J Infect Dis"},{"issue":"suppl 3","key":"R27-20260107","doi-asserted-by":"crossref","first-page":"S320","DOI":"10.2105\/AJPH.2013.301598","article-title":"American Indian and Alaska Native infant and pediatric mortality, United States, 1999-2009.","volume":"104","author":"Wong","year":"2014","journal-title":"Am J Public Health"},{"key":"R28-20260107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archpediatrics.2009.44","article-title":"Impact of immunizations on the disease burden of American Indian and Alaska native children.","volume":"163","author":"Singleton","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R29-20260107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1155\/2015\/613820","article-title":"Invasive disease due to Haemophilus influenzae type A in children in Canada\u2019s north: A priority for prevention.","volume":"26","author":"Boisvert","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R30-20260107","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1503\/cmaj.109-5047","article-title":"Vaccine needed for Aboriginal children.","volume":"187","author":"Shuchman","year":"2015","journal-title":"CMAJ"},{"key":"R31-20260107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14745\/ccdr.v43i05a01","article-title":"The emerging Haemophilus influenzae serotype a infection and a potential vaccine: implementation science in action.","volume":"43\u20135","author":"Barreto","year":"2017","journal-title":"Can Commun Dis Rep"},{"key":"R32-20260107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.14745\/ccdr.v43i05a02","article-title":"Developing a vaccine for Haemophilus influenzae serotype a: proceedings of a workshop.","volume":"43\u20135","author":"Cox","year":"2017","journal-title":"Can Commun Dis Rep"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:44:25Z","timestamp":1786041865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00004"}},"subtitle":["Clinical Description of an Emerging Pathogen\u2014Alaska, 2002\u20132014"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001764","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}